Technology

3

Antiviral Molnupiravir Reduces Risk of Hospitalization/Death by ~50 Percent

3 years ago

Anonymous $WHrWmjSJBZ

https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/

Antiviral Molnupiravir Reduces Risk of Hospitalization/Death by ~50 Percent

Oct 1, 2021, 5:24pm UTC

https://www.merck.com/news/merck-and-ridgebacks-investigational-oral-antiviral-molnupiravir-reduced-the-risk-of-hospitalization-or-death-by-approximately-50-percent-compared-to-placebo-for-patients-with-mild-or-moderat/